Comparative Bioavailability of Ranitidine Tablets in Healthy Volunteers

AuthorReza Aboofazelien
AuthorAlireza Shafaatien
Issued Date2002-12-31en
AbstractThe pharmacokinetic parameters of domestic and imported ranitidine hydrochloride tablets (Ranitidine, formulated and manufactured by Kharazmi Pharmaceuticals, Iran, and Zantac® manufactured by Glaxo, UK) were measured in 14 healthy subjects following oral administration of a single 300-mg dose of each brand and compared for bioequivalence evaluation.en
DOIhttps://doi.org/10.22037/ijpr.2010.2en
URIhttps://brieflands.com/journals/ijpr/articles/129835en
KeywordHPLC Detectionen
KeywordZantac®en
KeywordRanitidineen
KeywordPharmacokinetic parametersen
KeywordComparative bioavailabilityen
KeywordBioequivalenten
PublisherBrieflandsen
TitleComparative Bioavailability of Ranitidine Tablets in Healthy Volunteersen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
IJPR_Volume Volume 1_Issue Number 1_Pages 1-6.pdf
Size:
70.28 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF